Orion bringing new CMO capabilities, products and offers to CPhI 2014

Espoo, Finland: -Leading European research-based life sciences manufacturer Orion Corporation today announced its intention to take a prominent place at the upcoming pharmaceutical event, CPhI Worldwide, in Paris next month with an exhibition stand showcasing its services and products for the pharmaceutical industry.

The Orion team on stand 6K59 in Hall 6 at Paris Nord Villepinte will include a strong representation from the corporation’s contract manufacturing arm, with details of key new capabilities and product ranges. The team’s aim is to increase awareness of Orion’s advanced CMO capabilities, including formulation and filling, liquids, tablets and packaging.

These include hormonal semi-solids, gels and solutions being produced to very high quality standards from the group’s brand new/extended manufacturing facility in Finland.

Steriles and injectables

The Orion team will also have details of new sterile and injectable as well as key licensing and custom manufacturing opportunities.

CPhI Worldwide is a key event for Orion, with the group having been a consistent presence at the show almost since it was first staged in 1989.

The Orion show team also intends to take full advantage of the CPhI networking facilities to meet existing and potential customers and other business contacts. They are inviting any attendees interested in face-to-face meetings to contact the company in advance of the event.

About Orion Corporation

Orion is a globally operating developer of pharmaceuticals and diagnostic tests. The company has been innovatively building well-being since 1917; initially in its native country Finland and now has a direct presence in 21 European countries.

Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. It is continuously developing new drugs and treatment methods.

Orion and Fermion product and service offerings involve APIs and finished dosage forms as well as a capable marketing and sales network made available for partners’ licensing opportunities.Both Orion and Fermion also offer high value pharmaceutical contract manufacturing services for global markets.

Orion’s is a clear market leader main market in its Finland and also markets its products in more than 100 countries worldwide. The Group’s human pharmaceuticals sales organisation covers almost all key European markets. Several collaboration partners distribute Orion products in overseas markets.

All Orion manufacturing and most of its R&D operations are in Finland, with the group headquarters in Espoo, a short distance west of Helsinki. Orion employs some 3,500 people and in 2013 reported total worldwide sales of EUR 1,007 million. Orion A and B shares are listed on NASDAQ OMX Helsinki.

About CPhl Worldwide

CPhI Worldwide bills itself as ‘the number one Pharma sourcing event’, offering delegates opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators, as well as gain insights on latest industry trends. This year will mark the 25th Anniversary of the event’s foundation.

The 2014 show is being held 7-9 October at the Paris Nord Villepinte exhibition center and is expected to be the biggest CPhI Worldwide event to date, attracting more than 35,000 delegates from some 140 countries along with around 2,500 exhibitors.

The CPhl show is being held alongside three other zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events.

The Pre-Connect Conference on October 6 comprises eight modules on current industry ‘hot topics’ from API sourcing to Trends in Oncology and offers specifically themed networking opportunities.

CPhl is staged by leading global B2B events organizer and publisher, UBM Live.

More information at http://www.cphi.com/europe/home